tiprankstipranks
Trending News
More News >
Innovent Biologics (HK:1801)
:1801

Compare Innovent Biologics (1801) vs. Competitors

Compare
22 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Innovent Biologics
HK$89.30
HK$154.90B
120.22
169.79%
11 Buy
0 Hold
0 Sell
Strong Buy
Sino Biopharmaceutical
HK$6.83
HK$122.15B
30.60
129.19%
3 Buy
0 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$37.06
HK$153.19B
33.25
119.03%
2 Buy
1 Hold
0 Sell
Moderate Buy
Akeso, Inc.
HK$127.60
HK$117.54B
-125.34
125.84%
8 Buy
2 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$23.96
HK$40.05B
-24.53
134.70%
0 Buy
1 Hold
1 Sell
Moderate Sell
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$36.41B
40.91
183.90%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1801
Innovent Biologics
89.30
55.45
163.81%
HK:1177
Sino Biopharmaceutical
6.83
4.02
142.97%
HK:2269
Wuxi Biologics (Cayman)
37.06
20.16
119.29%
HK:9926
Akeso, Inc.
127.60
72.20
130.32%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.16
14.68
140.08%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
67.00
44.50
197.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts